Evan Lockwood Rachlin
Director at Iambic Therapeutics, Inc. (IAM)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$956K
Total bought / sold$11.5M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 19SEC | IAMIambic Therapeutics, Inc. | Buy | 718,7502,588,248 held (+38%) | $16.00 | $11.5M | +8.3% |
- Buy
Director Evan Lockwood Rachlin bought $11.5M of IAM at $16.00 — first open-market purchase in our records; raises the stake by 38%.